ASO Author Reflections: Stage-Adjusted Reduced Follow-Up of Melanoma Patients is Justified and Cost Effective, Until Biomarkers to Predict Prognosis Have Been Identified

Anne Brecht Francken; Josette E H M Hoekstra-Weebers; Eric Deckers; Harald J Hoekstra

doi:10.1245/s10434-019-07611-5

ASO Author Reflections: Stage-Adjusted Reduced Follow-Up of Melanoma Patients is Justified and Cost Effective, Until Biomarkers to Predict Prognosis Have Been Identified

Anne Brecht Francken, Josette E H M Hoekstra-Weebers, Eric Deckers, Harald J Hoekstra^*

^*Corresponding author for this work

Health Psychology Research (HPR)

Research output: Contribution to journal › Editorial › Academic › peer-review

106 Downloads (Pure)

Original language	English
Pages (from-to)	1418-1419
Number of pages	2
Journal	Annals of Surgical Oncology
Volume	27
Issue number	5
Early online date	3-Sept-2019
DOIs	https://doi.org/10.1245/s10434-019-07611-5
Publication status	Published - 1-May-2020

Access to Document

10.1245/s10434-019-07611-5Licence: CC BY

ASO Author Reflections_ Stage-Adjusted Reduced Follow-Up of Melanoma Patients is Justified and Cost Effective, Until Biomarkers to Predict Prognosis Have Been IdentifiedFinal publisher's version, 145 KBLicence: CC BY

Handle.net

Persistent link

Cite this

@article{618b7e024a2e41ce8f7a2337ab58f252,

title = "ASO Author Reflections: Stage-Adjusted Reduced Follow-Up of Melanoma Patients is Justified and Cost Effective, Until Biomarkers to Predict Prognosis Have Been Identified",

author = "Francken, {Anne Brecht} and Hoekstra-Weebers, {Josette E H M} and Eric Deckers and Hoekstra, {Harald J}",

year = "2020",

month = may,

day = "1",

doi = "10.1245/s10434-019-07611-5",

language = "English",

volume = "27",

pages = "1418--1419",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer",

number = "5",

}

ASO Author Reflections: Stage-Adjusted Reduced Follow-Up of Melanoma Patients is Justified and Cost Effective, Until Biomarkers to Predict Prognosis Have Been Identified. / Francken, Anne Brecht; Hoekstra-Weebers, Josette E H M ; Deckers, Eric et al.
In: Annals of Surgical Oncology, Vol. 27, No. 5, 01.05.2020, p. 1418-1419.

Research output: Contribution to journal › Editorial › Academic › peer-review

TY - JOUR

T1 - ASO Author Reflections

T2 - Stage-Adjusted Reduced Follow-Up of Melanoma Patients is Justified and Cost Effective, Until Biomarkers to Predict Prognosis Have Been Identified

AU - Francken, Anne Brecht

AU - Hoekstra-Weebers, Josette E H M

AU - Deckers, Eric

AU - Hoekstra, Harald J

PY - 2020/5/1

Y1 - 2020/5/1

U2 - 10.1245/s10434-019-07611-5

DO - 10.1245/s10434-019-07611-5

M3 - Editorial

C2 - 31482389

SN - 1068-9265

VL - 27

SP - 1418

EP - 1419

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

IS - 5

ER -